Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Businessweek Archives

New Partners For Cardio Dynamics

BusinessWeek Investor -- Inside Wall Street

New Partners for CardioDynamics

For a tiny medical-device maker with a market cap of $211 million, CardioDynamics International (CDIC) has attracted a behemoth, General Electric, which last summer acquired warrants allowing it to buy as much as 5% of the company through its GE Marquette Medical Systems unit. Now the word is that another major company, Agilent Technologies, is poised to team up with CardioDynamics. A source close to the company says Agilent may also buy a stake in CardioDynamics, which makes a noninvasive patented device called BioZ Systems for monitoring and measuring cardiac functions in hospitals or outpatient settings. CardioDynamics technology is an alternative to the more expensive technique of surgical catheterization of the heart.

The pact with GE allows Marquette to sell CardioDynamics' devices to hospitals in the U.S. and overseas. In Agilent's case, CardioDynamics will integrate its BioZ technology with Agilent's bedside monitors that it sells to hospitals. Agilent has some 60% of the 300,000 monitors installed beside hospital beds. GE has 25%. And CardioDynamics' system will also be integrated in GE's own monitors at hospitals.

CardioDynamics stock has been pummeled this year, along with that of other medical-device makers. Jeffrey Kraws of Gruntal rates the stock, now trading at 4 5/16, a buy, with a 12-month target of 16. Analyst Andreas Dirnagl of Gerard Klauer Mattison expects the company to turn profitable next year, on revenues of $25 to $28 million.By Gene G. MarcialReturn to top

Return to top

blog comments powered by Disqus